Outlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Mary Ann Slack
Advertisement
Mary Ann Slack is Deputy Director, Office of Strategic Programs, Center for Drug Evaluation and Research (CDER), Food & Drug Administration.
Articles by Mary Ann Slack
Advertisement
Latest Updated Articles
Leveraging Health IT to Improve Drug DevelopmentPublished: August 1st 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
3
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
4
Redefining CRA Workflows Through Intelligent Automation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
